Miscellanea |
Concordance probability and discriminatory power in proportional hazards regression
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street, New York, New York 10021, U.S.A. gonenm{at}mskcc.org, hellerg{at}mskcc.org
The concordance probability is used to evaluate the discriminatory power and the predictive accuracy of nonlinear statistical models. We derive an analytical expression for the concordance probability in the Cox proportional hazards model. The proposed estimator is a function of the regression parameters and the covariate distribution only and does not use the observed event and censoring times. For this reason it is asymptotically unbiased, unlike Harrell's c-index based on informative pairs. The asymptotic distribution of the concordance probability estimate is derived using U-statistic theory and the methodology is applied to a predictive model in lung cancer.
Key Words: Censored data; c-index; Cox model; Predictive accuracy
Received November 2004. Revised June 2005.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Vazquez, A. Bayes-Genis, I. Cygankiewicz, D. Pascual-Figal, L. Grigorian-Shamagian, R. Pavon, J. R. Gonzalez-Juanatey, J. M. Cubero, L. Pastor, J. Ordonez-Llanos, et al. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure Eur. Heart J., May 1, 2009; 30(9): 1088 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zivanovic, M. M. Leitao, A. Iasonos, L. M. Jacks, Q. Zhou, N. R. Abu-Rustum, R. A. Soslow, M. M. Juretzka, D. S. Chi, R. R. Barakat, et al. Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems J. Clin. Oncol., April 20, 2009; 27(12): 2066 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gupta, P. I. Karakiewicz, C. G. Roehrborn, Y. Lotan, A. R. Zlotta, and S. F. Shariat Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer Clin. Cancer Res., November 15, 2008; 14(22): 7385 - 7390. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Ferrone, L. H. Tang, J. Tomlinson, M. Gonen, S. N. Hochwald, M. F. Brennan, D. S. Klimstra, and P. J. Allen Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified? J. Clin. Oncol., December 10, 2007; 25(35): 5609 - 5615. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Danila, G. Heller, G. A. Gignac, R. Gonzalez-Espinoza, A. Anand, E. Tanaka, H. Lilja, L. Schwartz, S. Larson, M. Fleisher, et al. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer Clin. Cancer Res., December 1, 2007; 13(23): 7053 - 7058. [Abstract] [Full Text] [PDF] |
||||


